BIO-TECHNE Corp — Director's Dealing 2015

Aug 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-08-07

Reporting Person: Kummeth Charles R. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-07	Common Stock	A	11522	—	Acquired	44377	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-07	Stock Option (Right to Buy)	$108.49	A	79517	Acquired	2022-08-07	Common Stock (79517)	Direct
2015-08-07	Stock Option (Right to Buy)	$108.49	A	79517	Acquired	2022-08-07	Common Stock (79517)	Direct
2015-08-07	Restricted Stock Unit	$	A	11522	Acquired		Common Stock (11522)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$67.46	2020-04-01	Common Stock (65000)	65000	Direct
Stock Option (Right to Buy)	$67.46	2020-04-01	Common Stock (50000)	50000	Direct
Stock Option (Right to Buy)	$86.25	2021-04-01	Common Stock (46316)	46316	Direct
Stock Option (Right to Buy)	$94.35	2021-08-12	Common Stock (80460)	80460	Direct
Restricted Stock Unit	$		Common Stock (11129)	11129	Direct

Footnotes

F1: Includes (i) 5,000 shares of restricted stock that vest on April 1, 2016, (ii) 5,102 shares for which the risk of forfeiture will lapse with respect to 2,551 shares on April 1, 2016 and April 1, 2017; (iii) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; and (iv) 11,522 shares for which the risks of forfeiture will lapse with respect to 3,840 shares on August 7, 2016 and 3,841 shares on each of August 7, 2017 and August 7, 2018.

F2: The option will vest pursuant to the following schedule: 8,125 shares on October 1, 2013, 1,354 shares on the first day of each month for the period beginning November 1, 2013 and ending March 1, 2017, and 1,361 shares on April 1, 2017.

F3: Fully exercisable pursuant to achievement of performance goals.

F4: The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018.

F5: Vests in full or in part if certain performance goals are achieved during each of the 2015, 2016 and 2017 fiscal years.

F6: Vests in full or in part if certain performance goals are achieved during each of the 2015, 2016 and 2017 fiscal years (previously reported in Table I).

F7: 19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019.

F8: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F9: Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.